FI852273A0 - Foerfarande foer framstaellning av en mot mekaniska belastningar stabiliserad vattenhaltig insulinberedning och dess anvaendning. - Google Patents

Foerfarande foer framstaellning av en mot mekaniska belastningar stabiliserad vattenhaltig insulinberedning och dess anvaendning.

Info

Publication number
FI852273A0
FI852273A0 FI852273A FI852273A FI852273A0 FI 852273 A0 FI852273 A0 FI 852273A0 FI 852273 A FI852273 A FI 852273A FI 852273 A FI852273 A FI 852273A FI 852273 A0 FI852273 A0 FI 852273A0
Authority
FI
Finland
Prior art keywords
plunger pipe
plate
stabiliserad
insulinberedning
belastningar
Prior art date
Application number
FI852273A
Other languages
English (en)
Other versions
FI80596C (fi
FI852273L (fi
FI80596B (fi
Inventor
Ulrich Grau
Gerhard Ross
Dietrich Hiller
Horst Paul Neubauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843443877 external-priority patent/DE3443877A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI852273A0 publication Critical patent/FI852273A0/fi
Publication of FI852273L publication Critical patent/FI852273L/fi
Application granted granted Critical
Publication of FI80596B publication Critical patent/FI80596B/fi
Publication of FI80596C publication Critical patent/FI80596C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Luminescent Compositions (AREA)
  • External Artificial Organs (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
FI852273A 1984-06-09 1985-06-06 Foerfarande foer framstaellning av en mot mekaniska belastningar stabiliserad vattenhaltig insulinberedning och anvaendning av ett fysiologiskt godtagbart fortjockningsmedel och en aktiv substans foer stabilisering av vattenhaltiga insulinpreparat. FI80596C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3421613 1984-06-09
DE3421613 1984-06-09
DE3421615 1984-06-09
DE3421615 1984-06-09
DE3443877 1984-12-01
DE19843443877 DE3443877A1 (de) 1984-06-09 1984-12-01 Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung

Publications (4)

Publication Number Publication Date
FI852273A0 true FI852273A0 (fi) 1985-06-06
FI852273L FI852273L (fi) 1985-12-10
FI80596B FI80596B (fi) 1990-03-30
FI80596C FI80596C (fi) 1990-07-10

Family

ID=27192050

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852273A FI80596C (fi) 1984-06-09 1985-06-06 Foerfarande foer framstaellning av en mot mekaniska belastningar stabiliserad vattenhaltig insulinberedning och anvaendning av ett fysiologiskt godtagbart fortjockningsmedel och en aktiv substans foer stabilisering av vattenhaltiga insulinpreparat.

Country Status (16)

Country Link
EP (1) EP0166971B1 (fi)
AT (1) ATE50502T1 (fi)
AU (1) AU575951B2 (fi)
CA (1) CA1258427A (fi)
DE (1) DE3576120D1 (fi)
DK (1) DK162255C (fi)
ES (1) ES8605679A1 (fi)
FI (1) FI80596C (fi)
GR (1) GR851393B (fi)
HU (1) HU200102B (fi)
IE (1) IE57998B1 (fi)
IL (1) IL75448A (fi)
NO (1) NO164277C (fi)
NZ (1) NZ212338A (fi)
PH (1) PH24118A (fi)
PT (1) PT80620B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179479C (no) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DK2349324T3 (en) 2008-10-17 2017-12-11 Sanofi Aventis Deutschland COMBINATION OF AN INSULIN AND A GLP-1 AGONIST
JP5973918B2 (ja) 2009-11-13 2016-08-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｇｌｐ−１アゴニスト及びメチオニンを含む薬学的組成物
KR101836070B1 (ko) 2009-11-13 2018-03-09 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ－１ 작용제, 인슐린 및 메티오닌을 포함하는 약제학적 조성물
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
EP3517122A1 (en) 2013-04-03 2019-07-31 Sanofi Treatment of diabetes mellitus by long-acting formulations of insulins
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2574889A (en) * 1947-10-06 1951-11-13 Leo Ab Methylated gelatin-insulin preparation
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
IL66610A (en) * 1981-08-27 1985-11-29 Lilly Co Eli Human proinsulin pharmaceutical formulations
FI78616C (fi) * 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
WO1985005036A1 (en) * 1984-04-30 1985-11-21 The Trustees Of Columbia University In The City Of Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch

Also Published As

Publication number Publication date
EP0166971B1 (de) 1990-02-28
CA1258427A (en) 1989-08-15
NO164277C (no) 1990-09-19
IE851431L (en) 1985-12-09
AU575951B2 (en) 1988-08-11
ES8605679A1 (es) 1986-01-16
ES543972A0 (es) 1986-01-16
HUT37893A (en) 1986-03-28
IE57998B1 (en) 1993-06-02
GR851393B (en) 1985-11-25
EP0166971A1 (de) 1986-01-08
NO852314L (no) 1985-12-10
ATE50502T1 (de) 1990-03-15
DK162255C (da) 1992-03-16
HU200102B (en) 1990-04-28
FI80596C (fi) 1990-07-10
DK254585D0 (da) 1985-06-06
DE3576120D1 (de) 1990-04-05
IL75448A (en) 1989-07-31
NZ212338A (en) 1989-02-24
NO164277B (no) 1990-06-11
FI852273L (fi) 1985-12-10
DK162255B (da) 1991-10-07
PT80620A (de) 1985-07-01
FI80596B (fi) 1990-03-30
PT80620B (pt) 1987-10-20
PH24118A (en) 1990-03-05
AU4342485A (en) 1985-12-12
IL75448A0 (en) 1985-10-31
DK254585A (da) 1985-12-10

Similar Documents

Publication Publication Date Title
FI852273A0 (fi) Foerfarande foer framstaellning av en mot mekaniska belastningar stabiliserad vattenhaltig insulinberedning och dess anvaendning.
JPS646543A (en) Vibration isolating device
EP0877912A4 (fi)
DE69010781D1 (de) Vorrichtung für die Thoraxdrainage.
AU543587B2 (en) Determining liquid level
ATE9032T1 (de) Verbindungsteil mit dichtungsring.
JPS5748615A (en) Magnet liquid level gage
SE8404732D0 (sv) Oil well drilling clay conditioner
DE3564858D1 (en) Arrangement with a sealed evacuated hollow body
USD276133S (en) Window pulley seal
ES257901U (es) Cabeza tomamuestras para medidor de velocidad de sedimenta- cion de sangre
ES272644U (es) Ventosa
JPS5748614A (en) Direct viewing type magnet liquid level gage
ES262731U (es) Soporte de motor de dos camaras con amortiguacion hidraulica.
KR880008212A (ko) 주화 선별장치
SE8903801D0 (sv) Foerfarande och anordning vid makroalgsodling
IT8023226V0 (it) Sonda di misura ad immersione.
SU1334960A1 (ru) Сейсмоприемник
JPS6196333U (fi)
SU1012496A1 (ru) Формовочный стол
IT1244222B (it) Sifone per il passaggio di fluidi, da correnti a superficie libera a correnti in pressione
RU93031533A (ru) Устройство для экстрагирования растительного сырья

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT